Reply

Affiliations

¹ Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio. Electronic address: drrishisingh@gmail.com.
² Lehmann Eye Center, Nacogdoches, Texas.
³ Martel Eye Medical Group, Rancho Cordova, California.
⁴ Houston Eye Associates Houston, Texas.
⁵ Ophthalmology Department, Kaplan Medical Center, Rehovot, Israel.
⁶ Ophthalmology Department, Szabolcs-Szatmár-Bereg County Hospital, Nyíregyháza, Hungary.
⁷ Department of Biomedical and Clinical Science Luigi Sacco, Luigi Sacco Hospital, University of Milan, Milan, Italy.
⁸ Asociación Para Evitar la Ceguera en México, Hospital Dr. Luis Sánchez Bulnes, Mexico City, Mexico.
⁹ Cataract, Glaucoma and Refractive Surgery Center, El Paso, Texas.
¹⁰ Poughkeepsie, New York.
¹¹ Alcon Research Ltd., Lake Forest, California.
¹² Department of Ophthalmology, Duke University, Durham, North Carolina.

Comment

Rishi P Singh et al. Ophthalmology. 2018 Jan.

. 2018 Jan;125(1):e11-e12.

doi: 10.1016/j.ophtha.2017.08.023.

¹ Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio. Electronic address: drrishisingh@gmail.com.
² Lehmann Eye Center, Nacogdoches, Texas.
³ Martel Eye Medical Group, Rancho Cordova, California.
⁴ Houston Eye Associates Houston, Texas.
⁵ Ophthalmology Department, Kaplan Medical Center, Rehovot, Israel.
⁶ Ophthalmology Department, Szabolcs-Szatmár-Bereg County Hospital, Nyíregyháza, Hungary.
⁷ Department of Biomedical and Clinical Science Luigi Sacco, Luigi Sacco Hospital, University of Milan, Milan, Italy.
⁸ Asociación Para Evitar la Ceguera en México, Hospital Dr. Luis Sánchez Bulnes, Mexico City, Mexico.
⁹ Cataract, Glaucoma and Refractive Surgery Center, El Paso, Texas.
¹⁰ Poughkeepsie, New York.
¹¹ Alcon Research Ltd., Lake Forest, California.
¹² Department of Ophthalmology, Duke University, Durham, North Carolina.

No abstract available

Comment on

Nepafenac 0.3% after Cataract Surgery in Patients with Diabetic Retinopathy: Results of 2 Randomized Phase 3 Studies.
Singh RP, Lehmann R, Martel J, Jong K, Pollack A, Tsorbatzoglou A, Staurenghi G, Cervantes-Coste Cervantes G, Alpern L, Modi S, Svoboda L, Adewale A, Jaffe GJ. Singh RP, et al. Ophthalmology. 2017 Jun;124(6):776-785. doi: 10.1016/j.ophtha.2017.01.036. Epub 2017 Mar 6. Ophthalmology. 2017. PMID: 28268098 Clinical Trial.
Re: Singh et al.: Nepafenac 0.3% after cataract surgery in patients with diabetic retinopathy: results of 2 randomized phase 3 studies (Ophthalmology. 2017;124:776-785).
Modjtahedi BS, Fong DS. Modjtahedi BS, et al. Ophthalmology. 2018 Jan;125(1):e10-e11. doi: 10.1016/j.ophtha.2017.08.024. Ophthalmology. 2018. PMID: 29268871 No abstract available.